Skip to main navigation Skip to search Skip to main content

Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer

  • Abdul Rafeh Naqash
  • , Justin D. McCallen
  • , Emma Mi
  • , Sanna Iivanainen
  • , Mona A. Marie
  • , Daria Gramenitskaya
  • , James Clark
  • , Jussi Pekka Koivunen
  • , Shravanti Macherla
  • , Sweta Jonnalagadda
  • , Shanker Polsani
  • , Rahim Ali Jiwani
  • , Maida Hafiz
  • , Mahvish Muzaffar
  • , Leonardo Brunetti
  • , Chipman R.G. Stroud
  • , Paul R. Walker
  • , Kun Wang
  • , Youngmin Chung
  • , Eytan Ruppin
    • Se Hoon Lee, Li V. Yang, David J. Pinato, Joo Sang Lee, Alessio Cortellini
  • University of Oklahoma
  • East Carolina University
  • University of North Carolina at Chapel Hill
  • Imperial College Healthcare NHS Trust
  • University of Oulu
  • Campus Bio-Medico University Hospital Foundation
  • Genentech, Inc
  • Circulogene
  • National Institutes of Health
  • Sungkyunkwan University
  • University of Eastern Piedmont

Research output: Contribution to journal › Article › peer-review

45   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Neuroscience